News Category: General News

Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day

SAN DIEGO –(BUSINESS WIRE)–Mar. 13, 2024– Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in the UBS Virtual CNS Day on Monday, March 18, 2024 at 2:00 p.m. Eastern Time . The conference will be held virtually. A live webcast of Acadia’s presentation will be

Acadia Announces Additions to Executive Team

SAN DIEGO –(BUSINESS WIRE)–Jan. 30, 2024– Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced two new appointments to its executive team. Jennifer J. Rhodes is joining the company as Executive Vice President, Chief Legal Officer and Secretary, and Kimberly J.